stockrowCencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Net margin
Cencora, Inc.'s net margin over the twelve months to 30 September 2026 was 1.03%. Over the past ten years it has ranged from −1.80% (fiscal 2020) to 1.03% (fiscal 2026) — the current reading is the highest in ten years. That is above the Medical Distribution industry median of −11.4% and above the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2026 | 1.03% | 0.55 |
| FY2025 | 0.48% | (0.03) |
| FY2024 | 0.51% | (0.16) |
| FY2023 | 0.67% | (0.04) |
| FY2022 | 0.71% | (0.01) |
| FY2021 | 0.72% | 2.52 |
| FY2020 | −1.80% | (2.28) |
| FY2019 | 0.48% | (0.51) |
| FY2018 | 0.99% | 0.75 |
| FY2017 | 0.24% | (0.73) |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Sep 2026 | 0.59% | (0.31) |
| Jun 2026 | 0.90% | (1.19) |
| Mar 2026 | 2.09% | 1.44 |
| Dec 2025 | 0.65% | 1.06 |
| 43 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| HSIC Henry Schein, Inc. compare | 3.07% |
| MCK McKesson Corporation compare | 1.12% |
| COR Cencora, Inc. | 1.03% |
| CAH Cardinal Health, Inc. compare | 0.71% |
| YI 111, Inc. Sponsored ADR compare | −0.75% |
| ACH Accendra Health, Inc. compare | −11.4% |
| COSM Cosmos Health Inc. compare | −33.1% |
| FOCL FocalTherics compare | −50.1% |
| AHG Akso Health Group Sponsored ADR compare | −61.3% |
| Medical Distribution industry median | −11.4% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement